These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17713881)

  • 21. [Cancer of the kidney in adults. Economic aspects].
    Prog Urol; 1997 Nov; 7(5):901-4. PubMed ID: 9458486
    [No Abstract]   [Full Text] [Related]  

  • 22. Rationing in cancer treatment: is the identification of essential cytotoxic drugs feasible?
    Sessa C
    Ann Oncol; 1999 Apr; 10(4):373-4. PubMed ID: 10370776
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cost-effectiveness of cancer drug treatments].
    Akazawa M
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():706-12. PubMed ID: 25831852
    [No Abstract]   [Full Text] [Related]  

  • 24. Putting a price on hope.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(17):1274-5. PubMed ID: 22914787
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacoeconomics and cost of cancer drugs].
    Camps Herrero C; Caballero Díaz C; Blasco Cordellat A
    Farm Hosp; 2010 Mar; 34 Suppl 1():12-5. PubMed ID: 20920852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Communicating with patients about chemotherapy costs.
    de Lemos ML
    J Clin Oncol; 2007 May; 25(15):2142; author reply 2142. PubMed ID: 17513825
    [No Abstract]   [Full Text] [Related]  

  • 27. Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments.
    Tannock IF; Ratain MJ; Goldstein DA; Lichter AS; Rosner GL; Saltz LB
    J Clin Oncol; 2021 Mar; 39(9):950-955. PubMed ID: 33555940
    [No Abstract]   [Full Text] [Related]  

  • 28. [Costs and benefits in post-surgical chemotherapy and follow-up].
    Zilli L
    Minerva Chir; 1989 Feb; 44(4):813-7. PubMed ID: 2497409
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.
    Cheung MC; Sabharwal M; Chambers A; Han D; Sabarre KA; Chan K
    J Clin Oncol; 2016 Apr; 34(12):1428-9. PubMed ID: 26884567
    [No Abstract]   [Full Text] [Related]  

  • 30. Managing oncology agents: an HMO's perspective.
    Jaramillo R
    Manag Care; 2007 Mar; 16(3 Suppl 4):16-8; discussion 18-9. PubMed ID: 18575218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fast track to personalized medicine?: whole-genome sequencing may lead to better cancer therapies.
    Nelson B
    Cancer Cytopathol; 2012 Oct; 120(5):283-4. PubMed ID: 23065928
    [No Abstract]   [Full Text] [Related]  

  • 32. Charting the Course: Use of Clinical Pathways to Improve Value in Cancer Care.
    Malin JL
    J Clin Oncol; 2020 Feb; 38(4):367-371. PubMed ID: 31804871
    [No Abstract]   [Full Text] [Related]  

  • 33. [Access to cancer care: the cost of treatment matters].
    Tirelli U
    Recenti Prog Med; 2014 May; 105(5):181-3. PubMed ID: 24873939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keynote comment: reimbursement for molecularly targeted anticancer agents.
    Tirelli U; de Castro G; Awada A
    Lancet Oncol; 2006 Jan; 7(1):2-3. PubMed ID: 16389172
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer treatment: not just a question of costs.
    Lancet; 2007 May; 369(9574):1665. PubMed ID: 17512833
    [No Abstract]   [Full Text] [Related]  

  • 36. "It's the economy, stupid": strategies for improved cost containment in cancer treatment.
    Sleijfer S
    Clin Pharmacol Ther; 2014 Apr; 95(4):365-7. PubMed ID: 24646487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic burden of cancer patients undergoing oral chemotherapy].
    Koinuma N
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1230-3. PubMed ID: 20647704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example].
    Stockelberg D; Heurgren M; Sjöli P; Väärt J; Mellqvist UH; Kron B
    Lakartidningen; 2003 Oct; 100(42):3316-8. PubMed ID: 14619042
    [No Abstract]   [Full Text] [Related]  

  • 39. How much time do nurses need to give chemotherapy?
    Becze E
    ONS Connect; 2011 Jan; 26(1):14-5. PubMed ID: 21355484
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient access schemes for high-cost cancer medicines.
    Williamson S
    Lancet Oncol; 2010 Feb; 11(2):111-2. PubMed ID: 20152762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.